)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Jiangsu Nhwa Pharmaceutical
Jiangsu Nhwa Pharmaceutical (002262) investor relations material
Jiangsu Nhwa Pharmaceutical Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary23 Oct, 2026
Executive summary
Q3 revenue rose 6.61% YoY to RMB1.557bn; attributable net income was nearly flat at RMB405.5m, while adjusted net income increased 1.06% to RMB413.5m.
YTD revenue grew 6.81% to RMB4.776bn and attributable net income rose 3.63% to RMB1.146bn.
Financial highlights
Q3 basic and diluted EPS were RMB0.40, flat YoY; YTD EPS was RMB1.14, up 4.59%.
YTD adjusted net income, excluding non-recurring items, was RMB1.159bn, up 4.59%; non-recurring losses totaled RMB13.32m.
Total assets were RMB9.906bn, up 7.41% from year-end; attributable equity was RMB8.799bn, up 9.21%.
Key financial ratios and metrics
YTD weighted-average ROE was 13.56%, down 0.75 percentage points YoY; Q3 ROE was 4.72%, down 0.42 points.
YTD operating cash flow was RMB858.6m, down 5.76% YoY.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Jiangsu Nhwa Pharmaceutical
- Revenue and profit rose steadily, supported by CNS drug innovation and strong margins.002262
H1 2026 - Revenue up 3.75%, net profit down 7.54%, strong R&D and cash flow, dividend proposed.002262H2 2025
- Revenue and net profit rose year-over-year, but operating cash flow declined sharply.002262Q1 2026
- Q3 2025 revenue and net profit rose 5.70% and 3.67% year-over-year, respectively.002262Q3 2025
- Net profit up 11.38% year-over-year, with strong CNS drug sales and R&D growth.002262H1 2025
- Q3 2024 saw double-digit revenue and profit growth, with robust cash flow and rising EPS.002262Q3 2024
- H1 revenue and net profit rose 15%+ on CNS drug growth and robust R&D pipeline.002262H1 2024
- 2024 revenue and net profit rose double digits, with strong CNS drug and digital health growth.002262H2 2024
- Q1 2025 net profit up 13.35% year-over-year on strong sales and investment returns.002262Q1 2025
Next Jiangsu Nhwa Pharmaceutical earnings date
H2 202619 Apr, 2027
Jiangsu Nhwa Pharmaceutical
Next Jiangsu Nhwa Pharmaceutical earnings date
H2 202619 Apr, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)